Skip to main content

Scheduled maintenance

Location search will not be available from Sunday, April 12 at 9:00 PM EDT until Sunday, April 12 at 11:00 PM EDT due to planned site maintenance. We apologize for any inconvenience.

Hide
Quest Diagnostics

Laboratory Testing in the Diagnosis and Management of Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)

Date: Friday, Jan 22, 2016

Description: Martin J. Bergman, MD discusses the seriousness of a diagnosis of rheumatoid arthritis for patients who are afflicted and the appropriate use and limitations of laboratory testing in the diagnosis and monitoring for rheumatoid disease activity.

Learning Objectives:

  • Understand the role of laboratory testing in the diagnosis of RA and PsA
  • Recognize proper lab screening prior to the initiation of Disease Modifying Antirheumatic Drugs (DMARDS) or biologic therapy
  • Discuss the role of lab testing in the monitoring of disease activity and medication toxicities.

Related content

On-Demand Webinar
Mutated Citrullinated Vimentin Antibody as an Alternative Marker for RA
Test FAQ
Tests for Autoimmune Diseases

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.